Speciality: Hematology
Description:
A warm welcome to all the medical professionals to this highly anticipated panel discussion on "An Eagle's View - Evidence-based Discussion on Iron Deficiency Anemia." Following our in-depth look at IDA, this session offers a unique opportunity for a dynamic and interactive exchange among experts. The goal is to address the multifaceted challenges in diagnosing and treating IDA in various patient populations, from managing comorbidities to navigating treatment resistance.
This panel will delve into pressing questions that arise in clinical practice. Topics will include the most effective strategies for iron repletion in patients with chronic inflammatory conditions, such as inflammatory bowel disease, where oral iron absorption is often impaired. The experts will also discuss the optimal use of intravenous iron formulations, considering factors like dosing, patient safety, and the cost-benefit analysis in different healthcare settings. This discussion will highlight the importance of personalized, evidence-based decision-making.
Therefore, get an overall knowledge of how to apply an evidence-based approach to the complexities of iron deficiency anemia in a panel discussion format. Absorb the shared knowledge, get your questions answered by experts, and follow Hidoc for more such insightful webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Imfinzi + Imjudo, EU approved for patients with advanced lung cancer and non-small cell lung cancer: AstraZeneca
2.
More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer
3.
Asymptomatic Brain Metastases in EGFR-Mutant NSCLC
4.
Mapping lifelong chronic health risks for childhood cancer survivors
5.
Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC
1.
Respiratory Ramifications of Systemic Disease: A Comprehensive Review
2.
Revolutionizing Lung Cancer Treatment: Exploring the Benefits of Wedge Resection Surgery
3.
Trends in Incidence, Care, and Surgery for Medullary Thyroid Cancer: A Review
4.
Cancer Care Advances: Metformin, Digital Tools, and Artificial Renal Support
5.
Molecular Mechanisms, Clinical Efficacy, and Stem Cell Therapy Integration in Leukemia Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
5.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation